Neuralink’s Brain-Computer Interface (BCI) technology, brain chip, has demonstrated its potential to restore mobility to those with paralysis. However, the brain chip’s technical challenges and ethical dilemmas have begun to surface after its first clinical trial. The human brain and machine connection raises heated ethical discussions about BCI’s potential implications.
View More Neuralink’s Gamble: Public Response After First Clinical Trial’s Failure
Elon Musk’s Neuralink has received FDA approval for first-in-human studies of their brain-computer interface implant. This approval comes after multiple controversies surrounding their preclinical treatment of animal subjects. BCI technology has several concerns, including invasive surgeries, adverse effects, and implant obsolescence. While the general public will not have access to BCIs for enhancement any time soon, it is crucial to consider the impact and regulation of this technology for patients that it could greatly benefit.
View More Neuralink Gains First-In-Human Approval as BCIs Advance Rapidly